109 related articles for article (PubMed ID: 17173244)
41. Reduction of salt sensitivity in stroke-prone spontaneously hypertensive rats administered an AT1 receptor antagonist during suckling.
Otani L; Yasumatsu T; Murakami M; Hayashi A; Kimoto K; Murakami T
Am J Hypertens; 2006 Sep; 19(9):979-84. PubMed ID: 16942944
[TBL] [Abstract][Full Text] [Related]
42. Pharmacology of losartan, an angiotensin II receptor antagonist, in animal models of hypertension.
Siegl PK; Kivlighn SD; Broten TP
J Hypertens Suppl; 1995 Jul; 13(1):S15-21. PubMed ID: 18800451
[TBL] [Abstract][Full Text] [Related]
43. Losartan improves the impaired function of endothelial progenitor cells in hypertension via an antioxidant effect.
Yao EH; Fukuda N; Matsumoto T; Kobayashi N; Katakawa M; Yamamoto C; Tsunemi A; Suzuki R; Ueno T; Matsumoto K
Hypertens Res; 2007 Nov; 30(11):1119-28. PubMed ID: 18250561
[TBL] [Abstract][Full Text] [Related]
44. Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney.
Ruiz-Ortega M; Ruperez M; Lorenzo O; Esteban V; Blanco J; Mezzano S; Egido J
Kidney Int Suppl; 2002 Dec; (82):S12-22. PubMed ID: 12410849
[TBL] [Abstract][Full Text] [Related]
45. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Jackson EK; Dubinion JH; Mi Z
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
[TBL] [Abstract][Full Text] [Related]
46. Comparative analysis of renal protein expression in spontaneously hypertensive rat.
Yu M; Wang X; Du Y; Chen H; Guo X; Xia L; Chen J
Clin Exp Hypertens; 2008 Jul; 30(5):315-25. PubMed ID: 18633755
[TBL] [Abstract][Full Text] [Related]
47. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
[TBL] [Abstract][Full Text] [Related]
48. The renal antifibrotic effects of angiotensin-converting enzyme inhibition involve bradykinin B2 receptor activation in angiotensin II-dependent hypertension.
Seccia TM; Belloni AS; Guidolin D; Sticchi D; Nussdorfer GG; Pessina AC; Rossi GP
J Hypertens; 2006 Jul; 24(7):1419-27. PubMed ID: 16794493
[TBL] [Abstract][Full Text] [Related]
49. Losartan and tempol treatments normalize the increased response to hydrogen peroxide in resistance arteries from hypertensive rats.
García-Redondo AB; Briones AM; Avendaño MS; Hernanz R; Alonso MJ; Salaices M
J Hypertens; 2009 Sep; 27(9):1814-22. PubMed ID: 19491705
[TBL] [Abstract][Full Text] [Related]
50. [Renal hemodynamics and development of renal fibrotic lesions during hypertension].
Placier S; Flamant M; Boffa JJ; Dussaule JC; Chatziantoniou C
Arch Mal Coeur Vaiss; 2006; 99(7-8):697-700. PubMed ID: 17061447
[TBL] [Abstract][Full Text] [Related]
51. Cardiac chymase converts rat proAngiotensin-12 (PA12) to angiotensin II: effects of PA12 upon cardiac haemodynamics.
Prosser HC; Forster ME; Richards AM; Pemberton CJ
Cardiovasc Res; 2009 Apr; 82(1):40-50. PubMed ID: 19147651
[TBL] [Abstract][Full Text] [Related]
52. A twofold genetic increase of ACE expression has no effect on the development of spontaneous hypertension.
Nassar I; Schulz A; Bernardy C; Garrelds IM; Plehm R; Huber M; Danser AH; Kreutz R
Am J Hypertens; 2008 Feb; 21(2):200-5. PubMed ID: 18174884
[TBL] [Abstract][Full Text] [Related]
53. Characterization of angiotensin II antagonism displayed by Ib, a novel nonpeptide angiotensin AT(1) receptor antagonist.
Wu J; Wang Q; Guo J; Hu Z; Yin Z; Xu J; Wu X
Eur J Pharmacol; 2008 Jul; 589(1-3):220-4. PubMed ID: 18571160
[TBL] [Abstract][Full Text] [Related]
54. Regional hemodynamic effects of neutral endopeptidase inhibition and angiotensin (AT(1)) receptor antagonism alone or in combination in conscious spontaneously hypertensive rats.
Gardiner SM; March JE; Kemp PA; Ballard SA; Bennett T
J Pharmacol Exp Ther; 2006 Oct; 319(1):340-8. PubMed ID: 16825530
[TBL] [Abstract][Full Text] [Related]
55. Captopril inhibits capillary degeneration in the early stages of diabetic retinopathy.
Zhang JZ; Xi X; Gao L; Kern TS
Curr Eye Res; 2007 Oct; 32(10):883-9. PubMed ID: 17963108
[TBL] [Abstract][Full Text] [Related]
56. Angiotension II receptor 1 blocker modifies the expression of apoptosis-related proteins and transforming growth factor-beta1 in prostate tissue of spontaneously hypertensive rats.
Yu W; Zhao YY; Zhang ZW; Guo YL; Jin J
BJU Int; 2007 Nov; 100(5):1161-5. PubMed ID: 17784886
[TBL] [Abstract][Full Text] [Related]
57. Losartan, an antagonist of AT1 receptor for angiotensin II, attenuates lipopolysaccharide-induced acute lung injury in rat.
Liu L; Qiu HB; Yang Y; Wang L; Ding HM; Li HP
Arch Biochem Biophys; 2009 Jan; 481(1):131-6. PubMed ID: 18940180
[TBL] [Abstract][Full Text] [Related]
58. [Renin-angiotensin system modulation: instructions for use].
Bellis A; Rozza F; Crispo S; Trimarco B
G Ital Cardiol (Rome); 2008 Feb; 9(2):79-89. PubMed ID: 18383770
[TBL] [Abstract][Full Text] [Related]
59. Late renal medullary effects of transient angiotensin II receptor blockade in immature spontaneously hypertensive rats.
Zicha J
Acta Physiol (Oxf); 2009 Jun; 196(2):191. PubMed ID: 19473124
[No Abstract] [Full Text] [Related]
60. Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases.
Ruiz-Ortega M; Rupérez M; Esteban V; Rodríguez-Vita J; Sánchez-López E; Carvajal G; Egido J
Nephrol Dial Transplant; 2006 Jan; 21(1):16-20. PubMed ID: 16280370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
